We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

125 hedge funds and large institutions have $390M invested in ImmunityBio in 2021 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 62 increasing their positions, 17 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

265% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 17

3.04% more ownership

Funds ownership: 4.19% → 7.23% (+3%)

2% more capital invested

Capital invested by funds: $381M → $390M (+$8.59M)

1% less funds holding

Funds holding: 126 → 125 (-1)

4% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 27

59% less call options, than puts

Call options by funds: $8.17M | Put options by funds: $19.9M

Holders
125
Holders Change
-1
Holders Change %
-0.79%
% of All Funds
2.18%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
62
Reduced
17
Closed
27
Calls
$8.17M
Puts
$19.9M
Net Calls
-$11.7M
Net Calls Change
+$15M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$49.6M
2
State Street
State Street
Massachusetts
+$30.7M
3
BlackRock
BlackRock
New York
+$28.4M
4
Northern Trust
Northern Trust
Illinois
+$14.3M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$13.3M

Top Sellers

1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$2.34M
2
Russell Investments Group
Russell Investments Group
United Kingdom
-$2.28M
3
HF
HRT Financial
New York
-$2.23M
4
Rafferty Asset Management
Rafferty Asset Management
New York
-$1.78M
5
LPL Financial
LPL Financial
California
-$1.52M
Name Holding Trade Value Shares
Change 		Change in
Stake
MOACM
26
Mutual of America Capital Management
New York
$1.72M -$713K -43,176 -26%
JF
27
Jump Financial
Illinois
$1.65M +$1.51M +91,305 +374%
VIA
28
Vident Investment Advisory
Georgia
$1.5M +$1.73M +104,736 New
AllianceBernstein
29
AllianceBernstein
Tennessee
$1.43M +$902K +54,600 +119%
MIC
30
Meridian Investment Counsel
California
$1.38M – – –
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$1.32M +$738K +44,681 +94%
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$1.27M +$847K +51,249 +135%
SSWM
33
Sheets Smith Wealth Management
North Carolina
$1.26M +$1.1M +66,503 +307%
EGM
34
Engineers Gate Manager
New York
$1.25M +$924K +55,913 +176%
State of Wisconsin Investment Board
35
State of Wisconsin Investment Board
Wisconsin
$1.24M +$727K +44,000 +104%
ProShare Advisors
36
ProShare Advisors
Maryland
$1.23M +$1.04M +62,807 +267%
Two Sigma Investments
37
Two Sigma Investments
New York
$1.22M +$1.41M +85,579 New
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$1.21M +$1.39M +84,372 New
Swiss National Bank
39
Swiss National Bank
Switzerland
$1.2M +$159K +9,600 +13%
TC
40
TwinBeech Capital
New York
$1.2M +$925K +56,014 +202%
CCA
41
Clearwater Capital Advisors
Illinois
$1.03M – – –
GT
42
Glenmede Trust
Pennsylvania
$953K -$156K -9,430 -12%
Arrowstreet Capital
43
Arrowstreet Capital
Massachusetts
$938K +$1.09M +65,700 New
Millennium Management
44
Millennium Management
New York
$909K -$177K -10,695 -14%
Squarepoint
45
Squarepoint
New York
$893K +$827K +50,050 +400%
Voloridge Investment Management
46
Voloridge Investment Management
Florida
$859K +$994K +60,169 New
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$822K +$485K +29,356 +104%
Bank of America
48
Bank of America
North Carolina
$804K +$332K +20,078 +55%
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$658K +$76.9K +4,653 +11%
Deutsche Bank
50
Deutsche Bank
Germany
$634K +$354K +21,414 +93%
1
2
3 4 5

IBRX Hedge Fund Activity: Q2 2021 in Review

125 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q2 2021, worth a combined $390M — up 2.3% from $381M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of IBRX and 26 opened new positions — a net loss of 1 holder — while 17 trimmed existing stakes and 62 added.

The largest buyer was Vanguard Group, adding an estimated $49.6M. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $2.34M sold.

  • 125 institutional investors held ImmunityBio (IBRX) as of Q2 2021, down from 126 in Q1 2021.
  • Funds reported $390M of ImmunityBio stock for Q2 2021, up 2.3% quarter-over-quarter.
  • 26 funds opened new ImmunityBio positions in Q2 2021 and 27 closed out, a net change of -1 holder.
  • The largest ImmunityBio buyer in Q2 2021 was Vanguard Group, an estimated $49.6M added.
  • The largest ImmunityBio seller in Q2 2021 was Dimensional Fund Advisors, an estimated $2.34M sold.

Based on aggregated 13F filings for Q2 2021.